News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Andrx Corporation (ADRX) Forms Pact To Market Generic Paxil



10/19/2005 5:11:16 PM

Andrx Corporation (Nasdaq:ADRX) ("Andrx") announced today that it has entered into an agreement with Genpharm Inc. ("Genpharm") to obtain exclusive U.S. marketing rights for bioequivalent versions of Paxil(R) (paroxetine) 10mg, 20mg, 30mg and 40mg tablets, pursuant to the FDA approved ANDA (abbreviated new drug application) belonging to a Genpharm affiliate (Alphapharm (Pty) Limited). Andrx plans to commence making shipments of this product shortly.

Read at Reuters
Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES